ROYAL BANK OF CANADA - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 43 filers reported holding REDHILL BIOPHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$1,000
-66.7%
4,750
+9.7%
0.00%
Q3 2022$3,000
+200.0%
4,329
+225.7%
0.00%
Q2 2022$1,000
-75.0%
1,329
-16.9%
0.00%
Q1 2022$4,000
-50.0%
1,600
-50.1%
0.00%
Q4 2021$8,000
-68.0%
3,207
-39.8%
0.00%
Q3 2021$25,000
-34.2%
5,323
-1.8%
0.00%
Q2 2021$38,000
+5.6%
5,421
+10.3%
0.00%
Q1 2021$36,000
-21.7%
4,913
-10.8%
0.00%
Q4 2020$46,000
-32.4%
5,509
-17.8%
0.00%
Q3 2020$68,000
+88.9%
6,702
+25.2%
0.00%
Q2 2020$36,000
+89.5%
5,354
+27.5%
0.00%
Q1 2020$19,000
+5.6%
4,198
+39.3%
0.00%
Q4 2019$18,000
-14.3%
3,0130.0%0.00%
Q3 2019$21,000
+10.5%
3,0130.0%0.00%
Q2 2019$19,000
-24.0%
3,0130.0%0.00%
Q1 2019$25,000
+56.2%
3,0130.0%0.00%
Q4 2018$16,000
-38.5%
3,013
+2.6%
0.00%
Q3 2018$26,000
+550.0%
2,938
+570.8%
0.00%
Q2 2018$4,000
+100.0%
4380.0%0.00%
Q1 2018$2,0000.0%4380.0%0.00%
Q4 2017$2,000
-50.0%
438
+15.9%
0.00%
Q3 2017$4,000
+33.3%
3780.0%0.00%
Q2 2017$3,000
-25.0%
3780.0%0.00%
Q1 2017$4,000
-98.2%
378
-98.2%
0.00%
Q2 2016$228,000
-12.0%
20,976
-0.9%
0.00%
Q1 2016$259,000
-4.1%
21,167
+0.9%
0.00%
Q4 2015$270,000
-0.4%
20,9760.0%0.00%
Q3 2015$271,000
-26.6%
20,9760.0%0.00%
Q2 2015$369,00020,9760.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Ibex Investors LLC 527,000$4,653,0002.58%
683 Capital Management, LLC 3,631,019$32,062,0002.08%
CVI Holdings, LLC 22,367$198,0000.33%
MENTA CAPITAL LLC 85,785$757,0000.26%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$3,717,0000.10%
Kepos Capital LP 218,800$1,932,0000.10%
Claret Asset Management Corp 47,522$420,0000.08%
Migdal Insurance & Financial Holdings Ltd. 389,914$3,443,0000.07%
Clear Harbor Asset Management, LLC 38,806$323,0000.06%
Orbimed Advisors 284,900$2,516,0000.03%
View complete list of REDHILL BIOPHARMA LTD shareholders